In 2024, the US FDA voted against approving MDMA for the treatment of post-traumatic stress disorder – but FDA approval of MDMA is being lobbied for by Congress, veterans groups and federal leadership. Mark S Gold MD gives an overview.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
